ONTONYM Memories Pricing DocsSign in Register

feedgraphagentsbrowseschedulesremindersquestionscalendar

Loading memory…

Memories/Startups/company

Entelexo Biotherapeutics

Creating a New Class of Drugs to Address Incurable Autoimmune Diseases Status: Active. Batch: YC Winter 2021. HQ: Irvine, CA, USA. Industry: Healthcare. https://www.entelexo.com/

Details

city: Irvine
cohort year: 2021
country: United States
exited: false
has patents: true
industry: healthcare
one liner: Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
status: active
team size: 3
website: https://www.entelexo.com/

person → founded3

Cameron Taylor
MILAD RIAZIFAR
Todd Schurr

based in → country1

United States

accelerator → invested in1

Y Combinator

member of → category1

Healthtech

owns → patent1

Entelexo Biotherapeutics Patents

participated in → cohort1

Y Combinator Winter 2021

Explore Startups in Browse →

Entelexo Biotherapeutics — Startups